Moderna, IAVI to commence Phase I trial of mRNA HIV vaccine trial in Africa
The Phase I trial will analyse for safety and immunogenicity of the mRNA HIV vaccine antigen in African populations.
South Africa
Latest in
South Africa
Moderna’s Covid-19 vaccine trial in Africa receives support from CRO Emmes
The CRO will carry out data and statistical assessment to determine the relative risks of Covid-19 and severe disease.
IGM Biosciences progresses Covid-19 antibody to two clinical trials
Two clinical trials will be conducted in the US and South Africa to assess intranasal doses of IGM-6268.
The dynamics of clinical research in Africa: 2016-21
Over the last five years, the conduct of clinical research in Africa has shown a steady increase, but the level…
By
SAHPRA grants approval to begin trial of PaxMedica’s long Covid-19 therapy
The trial will assess the tolerability, safety, efficacy and PK of two varying doses of suramin in adult LCS patients.
The Omicron variant – another reason to support equitable global vaccination coverage
The gaping inequity in global vaccination rates only ensures that new Covid-19 variants such as Omicron will continue to emerge.
By
In conversation: South Africa Covid-19 vaccine expert Shabir Madhi
Covid-19 vaccine investigator Shabir Madhi discusses South Africa’s susceptibility to a fourth wave, and much more.
By
Poor mental health hinders ART adherence among South Africans living with HIV
Progress on getting more HIV patients in South Africa to begin antiretroviral therapy and achieve viral suppression is lagging.
By